The company said it had begun a trial of its over-the-counter rapid test for detecting sexually transmitted infections (STI) such as chlamydia and gonorrhea, and aims to launch it by mid-2025.
Tag Archive for: diagnostics
If approved, the test, called Shield, could become the second blood-based test for CRC screening in the United States after Epigenomics’ Epi proColon, which was approved in 2016.
The Boston-based drug developer will use its proprietary technology along with Lilly’s expertise in oncology drugs to develop therapies for a range of solid tumors.
Novo Holdings announced today that it is buying a majority stake in the Austrian life sciences tools company Single Use Support, a provider of fluid management services.
Abbott’s i-STAT TBI cartridge has received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, allowing doctors to help assess patients with suspected concussion at the patient’s bedside and obtain lab-quality results in 15 minutes. Previously, the tests to help with the assessment of TBI were only cleared for use with plasma or serum, requiring samples to be sent to a lab for processing and testing.
The company said its results showed it was overcoming a slump in demand for its COVID-19 products and a decline in sales of a trio of established cancer drugs.
The Curry Rockefeller Group (CRG) is a full-service medical communications company, based in Tarrytown, NY.
Although the profile is not precise enough to definitively diagnose Alzheimer’s, it offers a convenient way for doctors to determine which patients need advanced testing, according to the company.
The U.S. Supreme Court on Monday declined to hear a lawsuit by CareDx over organ-rejection tests made by Natera and Eurofins Viracor, turning down another request to revisit the contentious issue of patent eligibility.
HHS also announced an investment of $600 million in 12 domestic COVID-19 test manufacturers.